Nyxoah SA Ordinary Shares
Compare this stock
NYXH Stock Report Card
$
15%
Performance
Score:
10/100
NYXH returned -15.83% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.
Technicals
Score:
14/100
NYXH receives a 14 of 100 based on 14 indicators. 2 are bullish, 12 are bearish.
Earnings
Score:
10/100
NYXH has missed earnings 5 times in the last 20 quarters.
Profit
Score:
10/100
Out of the last 13 quarters, NYXH has had 0 profitable quarters and has increased their profits year over year on 0 of them.
Volatility
Score:
45/100
NYXH has had a lower than average amount of volatility over the last 12 months giving it a score of 45 of 100.
Nyxoah SA Ordinary Shares Summary
Nasdaq / NYXH
Healthcare
Medical - Instruments & Supplies
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Checkout Similar Companies
NYXH scored poorly on our reportcard. Here are some similar companies and how they performed.
